BAP Council Member Details

Council Member

Professor Angela Roberts

Angela Roberts

University of Cambridge
Council Member until 2020

Angela Roberts graduated from the University of Sussex (1981) with a degree in Neurobiology. She obtained her PhD in neuroendocrinology (1985) from the laboratory of Professor Joe Herbert, Department of Anatomy, University of Cambridge. She had by then developed a strong interest in behavioural and cognitive neuroscience and so joined the Department of Experimental Psychology at Cambridge, first as a Wellcome Trust Postdoctoral Associate with Professor Trevor Robbins and then as a Royal Society University Research Fellow studying the neural and neurochemical basis of cognitive flexibility. She was appointed Lecturer in Department of Anatomy, Cambridge, in 1996 and became Professor of Behavioural Neuroscience in 2010. She is a Fellow of the Academy of Medical Sciences. She sits on the executive committee of both the Wellcome Trust/MRC funded Behavioural and Clinical Neuroscience Institute and Cambridge Neuroscience and previously sat on the European Brain and Behaviour Society committee, Society for Neuroscience committee for Animal research and the Council for Understanding Animals In Research. Her recent scientific contributions have been in establishing non-human primate models of trait anxiety and positive and negative emotion regulation, fractionating out the distinct prefrontal cognitive processes that may underlie the varied aetiology of affective disorders and elucidating the role of dopaminergic and serotonergic modulation of these processes essential for the more effective targeting of current pharmacotherapies. The computerised behavioural tasks for testing the cognitive capabilities of non-human primates that she developed with Professor Robbins are now used extensively by research laboratories around the world, in academia and Pharmaceutical companies.

Declaration of Interests

  1. Have you, in the past three years, had patents or inventions from which you may derive personal benefit in the area of psychopharmacology?
  2. No
  3. Have you, in the past three years, had ownership or part ownership of a company with interests in the area of psychopharmacology? (This would include holding the shares of major companies in one's own name, or those of dependent family members.)
  4. No
  5. Have you, in the past three years, accepted a personal retainer from any company with an interest in psychopharmacology?
  6. No
  7. Have you, in the past three years, acted as a consultant to any company with an interest in psychopharmacology?
  8. No
  9. Have you, in the past three years, acted as an expert witness, either friendly or hostile, to any company with an interest in psychopharmacology?
  10. No
  11. Have you, in the past three years, held a research grant from any company with an interest in psychopharmacology?
  12. Research grant with Shionogi to study anhedonia and its treatment in marmosets
  13. Have you, in the past three years, had membership of the speakers' bureau for any company?
  14. No
  15. Have you, in the past three years, accepted paid speaking engagements in industry supported symposia?
  16. No
  17. Have you, in the past three years, accepted travel or hospitality NOT related to a speaking engagement?
  18. No
  19. Have you, in the past three years, recruited patients for industry-sponsored studies?
  20. No
  21. If there is anything else you feel it necessary to disclose, please provide details below:
  22. No

Form completed on 30th July 2019